Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention | MicrobiomeTrials← Back to trialsNCT07626840
Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2028-06-01
Enrollment target: 5,000 participants Other microbiome trials you might be interested in
Ischemic Heart DiseaseIschemic Coronary Artery DiseaseACS (Acute Coronary Syndrome)
The purpose is to investigate if a strategy of routine OCT based diagnosis and guidance of PCI improves clinical outcome…
Leuven, BelgiumCompleted Sep 1, 2030
Acute Coronary SyndromeAtrial Fibrillation
The selection of the optimal antithrombotic therapy in patients with nonvalvular atrial fibrillation (AF) and acute coro…
Innsbruck, AustriaCompleted May 22, 2026